Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy
This article reviews the potential of commonly used drugs, including antidiabetics, anthelmintics, statins, and beta-blockers, as co-adjuvant therapies in cancer treatment. The study discusses how these drugs, originally used for other medical conditions, may improve cancer outcomes by modulating tumor progression, enhancing immune response, or reducing inflammation. The review highlights
June 26, 2025
No Comments